HablaRÉ: Self-applied Online Training for Correcting Emotional Reasoning Biases in Public Speakin… (NCT07051135) | Clinical Trial Compass
RecruitingNot Applicable
HablaRÉ: Self-applied Online Training for Correcting Emotional Reasoning Biases in Public Speaking Anxiety.
Spain20 participantsStarted 2025-05-01
Plain-language summary
The project aims to assess the feasibility of self-administered training for individuals with public speaking anxiety, specifically targeting the reduction of emotional reasoning bias. It seeks to evaluate the interventions' usability, acceptability, satisfaction and adherence/compliance rates. In addition, the study intends to determine the feasibility of conducting a potential randomised clinical trial to evaluate the true impact of the intervention on emotional reasoning biases and public speaking anxiety levels.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
. Be of legal age.
. Accept the informed consent.
. Adequately understand/read Spanish.
. Have access to a mobile device or computer with an Internet connection.
. Not receiving any other psychological treatment for public speaking anxiety during the study period.
. Have a score of 43 or higher on the Emotional reasoning scale (ERPSAS) AND/OR a score of 55 or higher on the Spanish version of the Public Speaking Anxiety Scale (PSAS-S) for fear of public speaking.
. If taking prescribed medication for anxiety/depression, have had no changes in dosage for at least one month before the procedure.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Usability and acceptability
Timeframe: 2 evaluations: at post-treatment (just after treatment completion on the 10th day) and at 1-month follow up.
2
Satisfaction with online training
Timeframe: 2 evaluations: at post-treatment (just after treatment completion on the 10th day) and at 1-month follow up.
3
Adherence rates
Timeframe: 2 evaluations: at post-treatment (just after treatment completion on the 10th day) and at 1-month follow up.
4
User interaction with the platform
Timeframe: 1 evaluation: at post-treatment (just after treatment completion on the 10th day).
. Having a severe mental disorder (bipolar disorder, schizophrenia, or other psychotic disorders) or substance abuse (alcohol or other substances) or having active suicidal plans (suicide item in the ODSIS depression questionnaire ≥ 2) that would prevent participation in the program.
. In the case of receiving medication, changes in medication during treatment will be evaluated but will not lead to exclusion.